Literature DB >> 30521121

Issue Information-Declaration of Helsinki.

.   

Abstract

Mesh：

Year:  2018        PMID： 30521121     DOI： 10.1002/jbmr.3277

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  5 in total

1.  Study on Clinical Significance of LncRNA EGOT Expression in Colon Cancer and Its Effect on Autophagy of Colon Cancer Cells.

Authors:  Yang Liu; Bo Zhang; Wen-Bin Cao; Hai-Yan Wang; Lei Niu; Guo-Zhi Zhang
Journal:  Cancer Manag Res       Date:  2020-12-31       Impact factor: 3.989

2.  Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells.

Authors:  Jun-Feng Hao; Pei Chen; He-Yi Li; Ya-Jing Li; Yu-Ling Zhang
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

3.  LncRNA NEAT1/miR-204/NUAK1 Axis is a Potential Therapeutic Target for Non-Small Cell Lung Cancer.

Authors:  Ming-Ming Zhao; Lin-Yang Ge; Liang-Feng Yang; Hai-Xia Zheng; Gang Chen; Li-Zheng Wu; Shao-Ming Shi; Nan Wang; Yan-Ping Hang
Journal:  Cancer Manag Res       Date:  2020-12-29       Impact factor: 3.989

4.  Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.

Authors:  Li-Fei Gao; Wei Li; Ya-Gang Liu; Cui Zhang; Wei-Na Gao; Liang Wang
Journal:  Front Oncol       Date:  2021-08-31       Impact factor: 6.244

5.  Comparison of the diagnostic performance of NBI, Laser-BLI and LED-BLI: a randomized controlled noninferiority trial.

Authors:  Takuma Higurashi; Keiichi Ashikari; Shigeki Tamura; Tomohiro Takatsu; Noboru Misawa; Tsutomu Yoshihara; Yuki Ninomiya; Yuki Okamoto; Masataka Taguri; Taku Sakamoto; Shiro Oka; Atsushi Nakajima; Shinji Tanaka; Takahisa Matsuda
Journal:  Surg Endosc       Date:  2022-04-11       Impact factor: 3.453
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.